Subtypes


Web

  • http://www.medworm.com/rss/medicalfeeds/source/Cell+Biochemistry+...
  • Artesunate-amodiaquine combination therapy in the absence of malarial parasite infection induces oxidative damage in female rats
  • http://journals.plos.org/plosmedicine/article?id=10.1371/journal....
  • 30. Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, et al. (2011) Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artem...
  • http://livertox.nlm.nih.gov/ArtemisininDerivatives.htm
  • PubMed Citation (Analysis of safety from two prospective controlled trials conducted in Liberia comparing 3 day courses of artesunate-amodiaquine to artemether-lumefantrine in treating uncomplicated Plasmodium falciparum malaria; ALT elevations occurred ...
  • http://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/mal...
  • Instructions for artesunate-amodiaquine and quinine are provided in Option 2 and 3.
  • http://www.doctorswithoutborders.org/article/malaria-fighting-oth...
  • The chosen drug is artesunate amodiaquine, which can be used both to prevent and to treat malaria.
  • http://www.uptodate.com/contents/treatment-of-uncomplicated-falci...
  • Zwang J, Olliaro P, Barennes H, et al. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 2009; 8:203.
  • http://www.biomedcentral.com/bmcmed/series/Malaria
  • Abstract , Full text , PDF , PubMed , Editor's summary In a meta-analysis of artesunate-amodiaquine (AS-AQ) treatment for malaria, there is variation in the AQ dose administered under different regimens and fixed dose combinations provide high efficacy, ...
  • 1 2 3 4 5 6 7 8 9

    News

    Videos

    FACT Consortium: Towards malaria treatment access for the poorest
           
    In 2002, DNDi created the FACT Consortium to develop two fixed-dose combination therapies with artesunate, an artemisinin derivative: ASAQ, developed in partnership with Sanofi in 2007; and ASMQ, developed in 2008 with the Brazilian partner Farmanguinhos ...

    Arjen Dondorp: The treatment of severe malaria
           
    Severe malaria and drug resistance Prof Arjen Dondorp is the Deputy Director and Head of Malaria Research at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. His main research interests include the pathophysiology and treatment ...